11:44 AM EST - IntelliPharmaCeutics International : Filed a New Drug Application with the U.S. Food and Drug Administration seeking authorization to market its Rexista® abuse-deterrent oxycodone hydrochloride extended release tablets. IntelliPharmaCeutics International
shares T.I are trading up $0.19 at $4.26.
